Cited by 262Cancer-related Molecular PathwaysDNA Repair MechanismsUbiquitin and proteasome pathways

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index; none of the 39 sources its claims cite is checked for support yet.

ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage

Open access

Abstract

The p53 tumor suppressor is activated after DNA damage to maintain genomic stability and prevent transformation. Rapid activation of p53 by ionizing radiation is dependent on signaling by the ATM kinase. MDM2 and MDMX are important p53 regulators and logical targets for stress signals. We found that DNA damage induces ATM-dependent phosphorylation and degradation of MDMX. Phosphorylated MDMX is selectively bound and degraded by MDM2 preceding p53 accumulation and activation. Reduction of MDMX level by RNAi enhances p53 response to DNA damage. Loss of ATM prevents MDMX degradation and p53 stabilization after DNA damage. Phosphorylation of MDMX on S342, S367, and S403 were detected by mass spectrometric analysis, with the first two sites confirmed by phosphopeptide-specific antibodies. Mutation of MDMX on S342, S367, and S403 each confers partial resistance to MDM2-mediated ubiquitination and degradation. Phosphorylation of S342 and S367 in vivo require the Chk2 kinase. Chk2 also stimulates MDMX ubiquitination and degradation by MDM2. Therefore, the E3 ligase activity of MDM2 is redirected to MDMX after DNA damage and contributes to p53 activation.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

DNA damage induces ATM- and Chk2-dependent phosphorylation of MDMX at C-terminal serines, promoting MDM2 binding, ubiquitination, and degradation of MDMX, which contributes to p53 activation. Reducing MDMX by RNAi enhances p53 response and cell-cycle arrest after ionizing radiation.

Key findings

  • DNA damage induces MDMX phosphorylation and degradation; phosphorylated MDMX is selectively bound and degraded by MDM2, and ATM-deficient fibroblasts fail to induce MDMX mobility shift/degradation after radiation.
  • Mass spectrometry mapped MDMX phosphorylation on S161 (post-IR), S342 (pre- and post-IR), S367 (pre- and post-IR), S391 (post-IR), and S403 (post-IR), with approximately 77% peptide coverage; S342 and S367 were confirmed by phosphopeptide-specific antibodies.
  • Mutation of S342, S367, and S403 each reduced MDM2-mediated polyubiquitination, with S367 having the most significant effect; the triple alanine mutant MDMX-3A was resistant to degradation after DNA damage and inhibited p53 activation more efficiently than wild-type MDMX.
  • Chk2 was required in vivo for S342 and S367 phosphorylation after irradiation; Chk2-null HCT116 cells showed less efficient MDMX degradation and reduced p53 stabilization, MDM2 induction, and p21 induction after 5 Gy. MDMX siRNA (200 nM) in U2OS cells increased p53 target induction after 10 Gy and made DNA synthesis inhibition after gamma irradiation significantly more efficient by BrdU ELISA (n=4).

Methods

  • Cell lines included MCF7, U2OS, H1299, Saos2, HCT116 wild-type/p53-null/Chk2-null, ATM-deficient Hs235.Sk, and normal human skin fibroblasts; experiments used MDMX point mutants, MDMX siRNA, retrovirus, ionizing radiation, MG132, caffeine, cycloheximide, and MDM2 antisense oligonucleotide.
  • Protein analysis used Western blot, gradient gel electrophoresis, immunoprecipitation, GST-MDM2 pull-down, calf intestinal phosphatase treatment, and BrdU incorporation ELISA; phosphorylation-specific antibodies against PS342 and PS367 were generated and validated.
  • Phosphorylation site mapping used FLAG-MDMX affinity purification, trypsin digestion, and LCQ DECA XP Plus ion trap MS/MS with SEQUEST/MUQUEST/FUZZYIONS; 32P metabolic labeling with 2-D phospho-amino-acid analysis and in vitro kinase reactions with ATM, Chk1, Chk2, Akt1, and CK1α were also performed.

Limitations

  • Stated in the paper: lack of a viable Chk1-null mammalian cell line and strong toxicity of Chk1 siRNA hampered investigation of Chk1’s role; lack of a PS403 antibody precluded testing direct ATM modification of S403; more rigorous testing of cooperative phosphorylation requires gene replacement to avoid MDMX overexpression; the Chk2-null result differed from a prior study, possibly due to experimental conditions.
  • Evident from the text: many conclusions rely on transfected/overexpressed MDMX and single versus triple mutants, with single mutants showing only minor differences in U2OS p53 activation; no animal models are reported, and the authors note Chk2 effects may be subtle and cell-line/damage-dose dependent.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/sj.emboj.7600812

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

53 Own result · 28 Own interpretation · 26 Not checked yet · 2 Own method · 1 No basis given

Verify all 39 references — free account
  • It may state two separate claims as one. 42
  • Probably not a substantial claim. 17
52 of 52
  • The paper relies on this without support.

    Caffeine's inhibition of MDMX phosphorylation and degradation after radiation is due to inhibition of ATM/ATR rather than other caffeine effects.

    “MCF7 cells were treated with caffeine to inhibit ATM/ATR.”
    “This treatment partially inhibited the mobility shift and degradation of MDMX after radiation (Figure 3B).”
  • The paper relies on this without support.

    MDMX siRNA and stable knockdown specifically reduce MDMX levels without off-target effects.

    “U2OS cells were transfected with MDMX siRNA for 48 h, followed by treatment with 10 Gy gamma irradiation.”
    “Similar results were also observed using MCF7 cells with stable knockdown of MDMX (data not shown).”
  • The paper relies on this without support.

    The Chk2-A347 mutant is kinase-dead and can act as a dominant-negative inhibitor of Chk2.

    “kinase-dead Chk2-A347 mutant, activated myr-Akt1 and CK1a had no effect (Figure 9A).”
    “In wild-type HCT116 cells, Chk2-A347 reduced S367 phosphorylation, possibly through dominant-negative effect (Figure 9A).”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 43 references

Cited by

Sorted by citations

See all 262

Metadata

Authors
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J.
Affiliations
  • Moffitt Cancer Center (US)
  • Harvard University (US)
Corresponding author
Chen, Jiandong
Venue
The EMBO Journal
Published
2005-09-15
Volume
24
Issue
19
Pages
3411-3422
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2116326380
Cited by
260
References
43
Citations by year
2026: 5 · 2025: 4 · 2024: 8 · 2023: 2 · 2022: 8 · 2021: 10 · 2020: 10 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 17 · 2015: 17 · 2014: 15 · 2013: 20 · 2012: 20
FWCI
6.41
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Cancer Society
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
p53 activation, MDMX, MDM2, ATM kinase, Chk2, DNA damage response, protein phosphorylation, ubiquitination, protein degradation, ionizing radiation, E3 ubiquitin ligase, tumor suppressor
MeSH terms
Cells, Cultured, Chromatography, High Pressure Liquid, DNA Damage, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Gene Expression Regulation, Humans, Nuclear Proteins, Phosphorylation, Proto-Oncogene Proteins, Mass Spectrometry, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, RNA Interference, RNA, Small Interfering, Immunoprecipitation, Proto-Oncogene Proteins c-mdm2, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review